Publicacions Medicina Nuclear

Any 2024

Articles

• PSMA PET/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC)

Iván Henríquez, Bárbara Malave, Fernando López Campos, Elena Centelles Hidalgo, Rodrigo Muelas, Carlos Ferrer, Jesús Muñoz-Rodriguez, Agustina Méndez Villamón, María Cerrolaza Pascual, Joan Badia, Jordi Fuertes, Percy Hinojosa-Salas

Clinical Translational Oncology. 2025 Feb;27(2):706-715.